CMS has indicated it intends to collect utilization data through the Bridge to inform future coverage decisions, but that data alone does not guarantee a successor program
Discontinue use and consult a healthcare provider if you experience: Severe allergic reactions (rash, difficulty breathing, swelling), persistent injection site infections, or any concerning symptoms that do not resolve
For patients with severe obesity (BMI 40 or 35 with obesity-related complications), referral for evaluation of bariatric surgery may be appropriate according to American Society for Metabolic and Bariatric Surgery guidelines
Graves hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease
Semaglutide can be an effective tool for weight loss when used correctly
Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, et al